157 related articles for article (PubMed ID: 4144711)
1. Piperacetazine and chlorpromazine: a comparison.
Johnson AC; Kulkarni AS
Am J Psychiatry; 1973 May; 130(5):603-5. PubMed ID: 4144711
[No Abstract] [Full Text] [Related]
2. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
Kiev A; Güclü B; Kulkarni AS
Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
[No Abstract] [Full Text] [Related]
3. Clinical effectiveness of piperacetazine injection in schizophrenic patients: a controlled study.
Kulkarni AS
Adv Biochem Psychopharmacol; 1974; 9(0):691-9. PubMed ID: 4151770
[No Abstract] [Full Text] [Related]
4. Comparative evaluation of injectable chlorpromazine and piperacetazine.
McLaughlin B; Kulkarni AS
Psychosomatics; 1973; 14(4):220-1. PubMed ID: 4152813
[No Abstract] [Full Text] [Related]
5. Mesoridazine versus chlorpromazine in acute schizophrenia: a double-blind investigation.
Hamid TA; Wertz WJ
Am J Psychiatry; 1973 Jun; 130(6):689-92. PubMed ID: 4573820
[No Abstract] [Full Text] [Related]
6. Potential value of penfluridol and pipothiazine palmitate.
Gallant DM
Psychopharmacol Bull; 1975 Jan; 11(1):11-2. PubMed ID: 235769
[No Abstract] [Full Text] [Related]
7. Clinical evaluation of pipotiazine palmitate (19.552 R.P.) used on patients in an acute reception ward.
Elley JH; Petersen JH
Acta Psychiatr Scand Suppl; 1973; 241():75-82. PubMed ID: 4147514
[No Abstract] [Full Text] [Related]
8. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
Reschke RW
Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
[TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C
Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
[TBL] [Abstract][Full Text] [Related]
10. Pilot trials with long-acting pipotiazine injections.
Hakola A
Acta Psychiatr Scand Suppl; 1973; 241():31-42. PubMed ID: 4147509
[No Abstract] [Full Text] [Related]
11. Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients.
Gallant DM; Bishop MP
Curr Ther Res Clin Exp; 1970 Jun; 12(6):387-9. PubMed ID: 4987346
[No Abstract] [Full Text] [Related]
12. Piperacetazine in ambulatory chronic schizophrenic patients.
Rada RT; Donlon PT
Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
[No Abstract] [Full Text] [Related]
13. Piperacetazine vs. thioridazine for the control of schizophrenia in outpatients.
Rada RT; Donlon PT
Psychosomatics; 1972; 13(6):373-6. PubMed ID: 4153002
[No Abstract] [Full Text] [Related]
14. Psychopharmacological treatment of schizophrenia.
Lehmann HE
Schizophr Bull; 1975; (13):27-45. PubMed ID: 1851
[No Abstract] [Full Text] [Related]
15. A comparative trial of oxypertine and chlorpromazine in the treatment of acute psychoses.
Wadzisz FJ
Curr Ther Res Clin Exp; 1969 Dec; 11(12):784-92. PubMed ID: 4984044
[No Abstract] [Full Text] [Related]
16. [Application of NOSIE in the study of neuroleptic treatment].
Li Y
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Dec; 20(6):325-7. PubMed ID: 3329087
[No Abstract] [Full Text] [Related]
17. [Comparison of two antipsychotic drugs: chlorpromazine and clozapine (author's transl)].
Dick P; Rémy M; Rey-Bellet JJ
Ther Umsch; 1975 Aug; 32(8):497-500. PubMed ID: 1099714
[No Abstract] [Full Text] [Related]
18. Work performance versus clinical assessment in the evaluation of phenothiazine therapy.
Harper P; Chacon C
Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):50-5. PubMed ID: 9959
[No Abstract] [Full Text] [Related]
19. Antipsychotic medication in the treatment of schizophrenia.
Kane JM
Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
[TBL] [Abstract][Full Text] [Related]
20. Specific indications for different classes of phenothiazines.
Hollister LE; Overall JE; Kimbell I; Pokorny A
Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
